Bio Essence Corporation
BIOE · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $324 | $552 | $622 | $888 |
| % Growth | -41.3% | -11.3% | -30% | – |
| Cost of Goods Sold | $107 | $274 | $293 | $590 |
| Gross Profit | $217 | $277 | $328 | $298 |
| % Margin | 67% | 50.3% | 52.8% | 33.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $677 | $974 | $763 | $1,077 |
| SG&A Expenses | $677 | $1,066 | $839 | $1,156 |
| Sales & Mktg Exp. | $0 | $92 | $76 | $70 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $677 | $1,066 | $839 | $1,156 |
| Operating Income | -$459 | -$789 | -$511 | -$858 |
| % Margin | -141.8% | -143.1% | -82.2% | -96.6% |
| Other Income/Exp. Net | -$1,105 | -$11 | -$14 | $213 |
| Pre-Tax Income | -$1,565 | -$800 | -$525 | -$644 |
| Tax Expense | $1 | $2 | $3 | $3 |
| Net Income | -$1,309 | -$972 | -$810 | -$648 |
| % Margin | -404% | -176.2% | -130.3% | -72.9% |
| EPS | -0.034 | -0.022 | -0.025 | -0.02 |
| % Growth | -54.3% | 9% | -25% | – |
| EPS Diluted | -0.034 | -0.022 | -0.025 | -0.02 |
| Weighted Avg Shares Out | 38,009 | 35,954 | 33,009 | 33,009 |
| Weighted Avg Shares Out Dil | 38,009 | 35,954 | 33,009 | 33,009 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $17 | $19 | $48 |
| Depreciation & Amortization | $1 | $17 | $15 | $36 |
| EBITDA | -$1,562 | -$765 | -$497 | -$560 |
| % Margin | -482.1% | -138.7% | -79.9% | -63.1% |